Padmanabha Shenoy – Rheumacare
View Detailed Executive Profile →Professional Overview
- Padmanabha Shenoy founded RheumaCARE in April 2015, aiming to improve the management and treatment of rheumatic diseases.
- As the CEO of RheumaCARE, Shenoy has led initiatives to enhance patient care and support through innovative solutions in rheumatology.
- Prior to establishing RheumaCARE, Shenoy served as the Head of the Department of Rheumatology & Clinical Immunology at Amrita Institute of Medical Sciences from September 2010 until April 2015.
- During tenure at Amrita Institute of Medical Sciences, significant contributions were made to clinical research and the advancement of rheumatologic care practices.
- Under Shenoy's leadership, RheumaCARE has implemented educational programs aimed at raising awareness about rheumatic diseases among healthcare professionals and patients.
- The organization has faced challenges related to funding and resource allocation, which were navigated through strategic partnerships and community engagement.
- RheumaCARE has prioritized the development of digital health platforms to facilitate better communication and monitoring of patients' conditions.
- Shenoy has been a key advocate for policy changes to improve healthcare access and quality for individuals affected by rheumatic diseases.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Amrita Institute of Medical Sciences | Head, Department of Rheumatology & Clinical Immunology | Sep 2010 – Apr 2015 |
| RheumaCARE | Founder & CEO | Apr 2015 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Rheumacare corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Padmanabha Shenoy's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Rheumacare's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)